Literature DB >> 1502994

Ketamine, Telazol, xylazine and detomidine. A comparative anesthetic drug combinations study in ponies.

H C Lin1, K R Branson, J C Thurmon, G J Benson, W J Tranquilli, W A Olson, A T Vähä-Vahe.   

Abstract

This study was designed to assess the effects of 5 anesthetic drug combinations in ponies: (1) ketamine 2.75 mg/kg, xylazine 1.0 mg/kg (KX), (2) Telazol 1.65 mg/kg, xylazine 1.0 mg/kg (TX), (3) Telazol 2 mg/kg, detomidine 20 micrograms/kg (TD-20), (4) Telazol 2 mg/kg, detomidine 40 micrograms/kg (TD-40), (5) Telazol 3 mg/kg, detomidine 60 micrograms/kg (TD-60). All drugs were given iv with xylazine or detomidine preceding ketamine or Telazol by 5 min. Heart rate was decreased significantly from 5 min to arousal after TD-20 but only at 60 and 90 min after TD-40 and TD-60 respectively. Respiratory rate was decreased significantly for all ponies. Induction time did not differ between treatments. Duration of analgesia was 10 min for KX, 22.2 min for TX, 27.5 min for TD-20, 32.5 min for TD-40, and 70 min for TD-60. Arousal time was significantly longer with detomidine and Telazol. Smoothness of recovery was judged best in ponies receiving KX and TD-40. All ponies stood unassisted 30 min after signs of arousal.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1502994      PMCID: PMC8117853     

Source DB:  PubMed          Journal:  Acta Vet Scand        ISSN: 0044-605X            Impact factor:   1.695


  13 in total

1.  Cardiovascular effects of detomidine, a new alpha 2-adrenoceptor agonist, in the conscious pony.

Authors:  R D Sarazan; W A Starke; G F Krause; H E Garner
Journal:  J Vet Pharmacol Ther       Date:  1989-12       Impact factor: 1.786

2.  Cardiopulmonary effects of continuous intravenous infusion of guaifenesin, ketamine, and xylazine in ponies.

Authors:  S A Greene; J C Thurmon; W J Tranquilli; G J Benson
Journal:  Am J Vet Res       Date:  1986-11       Impact factor: 1.156

3.  Effects on Bay Va 1470 on cardiovascular parameters in ponies.

Authors:  H E Garner; J F Amend; J P Rosborough
Journal:  Vet Med Small Anim Clin       Date:  1971-10

4.  2-(Ethylamino)-2-(2-thienyl) cyclohexanone-HCl (CI-634): a taming, incapacitating, and anesthetic agent for the cat.

Authors:  G Chen; C R Ensor
Journal:  Am J Vet Res       Date:  1968-04       Impact factor: 1.156

Review 5.  Pharmacologic effects of ketamine and its use in veterinary medicine.

Authors:  M Wright
Journal:  J Am Vet Med Assoc       Date:  1982-06-15       Impact factor: 1.936

6.  Ketamine--its pharmacology and therapeutic uses.

Authors:  P F White; W L Way; A J Trevor
Journal:  Anesthesiology       Date:  1982-02       Impact factor: 7.892

7.  Single-dose pharmacokinetics of detomidine in the horse and cow.

Authors:  J S Salonen; T Vähä-Vahe; O Vainio; O Vakkuri
Journal:  J Vet Pharmacol Ther       Date:  1989-03       Impact factor: 1.786

8.  Xylazine and tiletamine-zolazepam anesthesia in horses.

Authors:  J A Hubbell; R M Bednarski; W W Muir
Journal:  Am J Vet Res       Date:  1989-05       Impact factor: 1.156

9.  Evidence for increased vagal tone and enhancement of baroreceptor reflex activity after xylazine (2-(2,6-dimethylphenylamino)-4-H-5,6-dihydro-1,3-thiazine) in anesthestized dogs.

Authors:  M J Antonaccio; R D Robson; L Kerwin
Journal:  Eur J Pharmacol       Date:  1973-09       Impact factor: 4.432

10.  The pharmacokinetics of xylazine hydrochloride: an interspecific study.

Authors:  R Garcia-Villar; P L Toutain; M Alvinerie; Y Ruckebusch
Journal:  J Vet Pharmacol Ther       Date:  1981-06       Impact factor: 1.786

View more
  2 in total

1.  A comparison of romifidine and xylazine when used with diazepam/ketamine for short duration anesthesia in the horse.

Authors:  C L Kerr; W N McDonell; S S Young
Journal:  Can Vet J       Date:  1996-10       Impact factor: 1.008

2.  Comparison of ketamine-diazepam with ketamine-xylazine anesthetic combinations in sheep spontaneously breathing and undergoing maxillofacial surgery.

Authors:  Fatih Özkan; Nilüfer Çakır-Özkan; Ahmet Eyibilen; Tamer Yener; Ünal Erkorkmaz
Journal:  Bosn J Basic Med Sci       Date:  2010-11       Impact factor: 3.363

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.